StonvexLoading…
StonvexStonvexStonvexCore line items from ALSN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.01B | $3.23B | $3.04B | $2.77B |
Operating Income | $880.00M | $992.00M | $919.00M | $784.00M |
Net Income | $623.00M | $731.00M | $673.00M | $531.00M |
EPS (Diluted) | $7.33 | $8.31 | $7.40 | $5.53 |
Total Assets | $6.08B | $5.34B | $5.03B | $4.67B |
Total Liabilities | $4.21B | $3.69B | $3.79B | $3.80B |
Cash & Equivalents | $1.50B | $781.00M | $555.00M | $232.00M |
Free Cash Flow OCF − CapEx | $661.00M | $658.00M | $659.00M | $490.00M |
Shares Outstanding | 85.00M | 88.00M | 91.00M | 96.00M |